Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
about
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activitiesRole of plasma kallikrein in diabetes and metabolismThe hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykininBiological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation.In vivo roles of factor XII.A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk.Defective glycosylation of coagulation factor XII underlies hereditary angioedema type IIICleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12Differential VASP phosphorylation controls remodeling of the actin cytoskeleton.A new type of plasma prekallikrein deficiency associated with homozygosity for Gly104Arg and Asn124Ser in apple domain 2 of the heavy-chain region.The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans.Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells.Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases.High-molecular-weight kininogen is a binding protein for tissue prokallikrein.Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP.
P2860
Q26775616-83CFB1E1-4D17-443D-92FE-09BABA4EC6E3Q27016431-D2631BCA-1D88-4936-A5E1-3E1628771BAEQ28216096-8079D384-5254-4B1C-A5EF-03AED97A1E11Q34118329-E1151314-0DB9-4A69-8024-CDE175F8BAACQ34300714-E8BED42D-6CCA-4C9E-927E-35845ED5A0EEQ34402606-093AD3C5-B4A6-4929-A06A-86FB1E61F845Q35700453-5013ACD3-CA74-484B-9DE8-5FDB2144D6EDQ36929003-75DC3EC1-7C0E-413A-B4E8-228A0E012D5EQ37411570-B78D7C5F-C876-44FF-AD49-93F9C61EEC01Q38300438-4D3D77E7-7E86-4E04-A80B-FD5D5F3EB330Q38632499-85FC391F-135F-45C9-AE7D-0D56364A0DB7Q39458351-8906E9F9-ED26-4BCA-97E8-B55123821720Q40762400-F1301248-CE8A-4868-9250-61BC341A4BB2Q40874868-F72ECD74-3C2A-4A09-8BB8-6E7E75C77957Q41665262-970580B2-562C-4E69-8FFC-728EC2C8F1DAQ45171371-5BA65FB8-FA63-409A-B99E-3691B3684DB4Q47246908-DCB925CF-CA8B-4179-8442-EE5D0548336BQ51173170-9E7D70F5-228C-4CE8-AC95-2145BE1891EE
P2860
Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mapping of the discontinuous H ...... itical role of apple domain-2.
@ast
Mapping of the discontinuous H ...... itical role of apple domain-2.
@en
type
label
Mapping of the discontinuous H ...... itical role of apple domain-2.
@ast
Mapping of the discontinuous H ...... itical role of apple domain-2.
@en
prefLabel
Mapping of the discontinuous H ...... itical role of apple domain-2.
@ast
Mapping of the discontinuous H ...... itical role of apple domain-2.
@en
P2093
P2860
P356
P1476
Mapping of the discontinuous H ...... itical role of apple domain-2.
@en
P2093
P2860
P304
25777-25784
P356
10.1074/JBC.274.36.25777
P407
P577
1999-09-01T00:00:00Z